| Cell-type-specific analysis of alternative polyadenylation using single-cell transcriptomics data ED Shulman, R Elkon Nucleic acids research 47 (19), 10027-10039, 2019 | 69 | 2019 |
| A cell-type-specific atlas of the inner ear transcriptional response to acoustic trauma B Milon, ED Shulman, KS So, CR Cederroth, EL Lipford, M Sperber, ... Cell reports 36 (13), 2021 | 63 | 2021 |
| Genome-wide association meta-analysis identifies 48 risk variants and highlights the role of the stria vascularis in hearing loss N Trpchevska, MB Freidin, L Broer, BC Oosterloo, S Yao, Y Zhou, B Vona, ... The American Journal of Human Genetics 109 (6), 1077-1091, 2022 | 35 | 2022 |
| Systematic identification of functional SNPs interrupting 3’UTR polyadenylation signals ED Shulman, R Elkon PLoS Genetics 16 (8), e1008977, 2020 | 32 | 2020 |
| Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome G Dinstag, ED Shulman, E Elis, DS Ben-Zvi, O Tirosh, E Maimon, ... Med 4 (1), 15-30. e8, 2023 | 11 | 2023 |
| Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potential Y Malka, F Alkan, S Ju, PR Körner, A Pataskar, E Shulman, ... Molecular Cell 82 (20), 3840-3855. e8, 2022 | 9 | 2022 |
| Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations TG Chang, Y Cao, ED Shulman, U Ben-David, AA Schäffer, E Ruppin npj Precision Oncology 7 (1), 54, 2023 | 2 | 2023 |
| Genetic mapping of developmental trajectories for complex traits and diseases ED Shulman, R Elkon Computational and Structural Biotechnology Journal 19, 3458-3469, 2021 | 2 | 2021 |
| MYC Induces Immunotherapy and IFNγ Resistance through Downregulation of JAK2 E Markovits, O Harush, EN Baruch, ED Shulman, A Debby, O Itzhaki, ... Cancer immunology research 11 (7), 909-924, 2023 | 1 | 2023 |
| Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues N Sanghvi, C Calvo-Alcañiz, P Rajagopal, S Scalera, V Canu, S Sinha, ... bioRxiv, 2023.10. 30.564810, 2023 | 1 | 2023 |
| ENLIGHT: Pancancer response prediction to targeted and immunotherapies via tumor transcriptomics. R Aharonov, G Dinstag, E Shulman, E Elis, D Ben-Zvi, O Tirosh, ... Journal of Clinical Oncology 40 (16_suppl), e13556-e13556, 2022 | 1 | 2022 |
| Abstract LB242: Prediction of patient response to neoadjuvant chemotherapy in breast cancer from their deconvolved tumor microenvironment transcriptome SR Dhruba, S Sahni, B Wang, D Wu, Y Schmidt, E Shulman, S Sinha, ... Cancer Research 84 (7_Supplement), LB242-LB242, 2024 | | 2024 |
| Why does the loss of chromosomes 10 and the gain of 7 co-occur in gliomas NU Nair, AA Schäffer, ME Gertz, K Cheng, AD Sahu, G Leor, ED Shulman, ... Cancer Research 84 (6_Supplement), 2263-2263, 2024 | | 2024 |
| Integrated deep learning model for predicting DNA methylation and tumor types from histopathology in central nervous system tumors ED Shulman, DT Hoang, R Turakulov, Z Abdullaev, O Singh, ... Cancer Research 84 (6_Supplement), 886-886, 2024 | | 2024 |
| Chromosome 7 to the rescue: overcoming chromosome 10 loss in gliomas NU Nair, AA Schaffer, ME Gertz, K Cheng, J Zerbib, AD Sahu, G Leor, ... bioRxiv, 2024.01. 17.576103, 2024 | | 2024 |
| Predicting breast cancer patients response to neoadjuvant chemotherapy from the deconvolved transcriptome of different cell types in the tumor microenvironment SR Dhruba, S Sahni, B Wang, D Wu, Y Schmidt, E Shulman, S Sinha, ... MOLECULAR CANCER THERAPEUTICS 22 (12), 2023 | | 2023 |
| Abstract A018: Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations TG Chang, Y Cao, ED Shulman, U Ben-David, AA Schäffer, E Ruppin Molecular Cancer Therapeutics 22 (12_Supplement), A018-A018, 2023 | | 2023 |
| Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome. R Aharonov, G Dinstag, E Shulman, E Elis, D Ben-Zvi, O Tirosh, ... Journal of Clinical Oncology 41 (16_suppl), 1553-1553, 2023 | | 2023 |
| Prediction of patient response to targeted and immunotherapies from the tumor transcriptome in a wide set of indications and clinical trials G Dinstag, ED Shulman, E Elis, DS Ben-Zvi, O Tirosh, E Maimon, ... Cancer Research 83 (7_Supplement), 957-957, 2023 | | 2023 |
| Abstract LB_A02: Predicting breast cancer patients’ response to neoadjuvant chemotherapy from the deconvolved transcriptome of different cell types in the tumor microenvironment SR Dhruba, S Sahni, B Wang, D Wu, Y Schmidt, E Shulman, S Sinha, ... NaN, LB_A02-LB_A02, 2023 | | 2023 |
Ran ElkonTel Aviv UniversityVerified email at tauex.tau.ac.il
